According to CNBC, Abbott Laboratories shares jumped almost 11% after the maker of Ensure nutrition shakes raised its full-year adjusted earnings guidance to $5.45 to $5.60 per share, up from a prior range of $5.38 to $5.58, compared with the FactSet consensus of $5.47. ManpowerGroup surged 33% after the employment agency forecast third-quarter revenue growth of 2% to 6%, above the FactSet estimate of 1.7%, and reported second-quarter adjusted earnings of 99 cents per share on revenue of $4.9 billion. Cintas rose 6.5% after Bank of America upgraded the uniform rental company to buy from neutral following better-than-expected fiscal fourth-quarter results. Cinemark and Imax fell almost 4% and 2%, respectively, after Wells Fargo cut both stocks to equal weight from overweight. AST SpaceMobile dropped more than 16% after announcing plans to sell $1 billion of convertible senior notes due 2034 in a private offering. UnitedHealth gained 4% after reporting adjusted second-quarter earnings of $6.38 per share on revenue of $112.03 billion and raising its full-year earnings outlook. Taiwan Semiconductor Manufacturing fell 2% after lifting its full-year capital expenditure forecast to $60 billion to $64 billion and saying it will invest an additional $100 billion in Arizona. AtaiBeckley jumped 33% after Eli Lilly said it will buy the psychedelic drugmaker for $2.8 billion, or $6.75 per share in cash, with up to another $2.50 per share tied to milestones. GE Aerospace slipped 4% despite second-quarter adjusted earnings of $2.02 per share on adjusted revenue of $12.63 billion and a higher full-year outlook. United Airlines fell more than 1% after issuing third-quarter earnings guidance of $2.50 to $3.50 per share and saying it expects $6 billion in added fuel costs. J.B. Hunt Transport Services climbed almost 7% after second-quarter earnings of $1.91 per share and revenue of $3.5 billion beat estimates. AeroVironment rose 4% after Raymond James upgraded the stock to outperform from market perform, and Rocket Companies gained more than 1% after Morgan Stanley raised its price target to $19 and reiterated a buy rating.